NORTHERN TRUST CORP - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 205 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$18,307,345
+7.7%
551,260
+2.3%
0.00%0.0%
Q3 2022$16,996,000
+3.6%
539,051
-0.1%
0.00%0.0%
Q2 2022$16,408,000
+17.4%
539,369
+0.2%
0.00%
+100.0%
Q1 2022$13,974,000
+24.5%
538,331
-2.2%
0.00%0.0%
Q4 2021$11,228,000
+3.5%
550,363
-2.4%
0.00%0.0%
Q3 2021$10,853,000
-15.9%
564,135
-3.1%
0.00%0.0%
Q2 2021$12,911,000
-8.0%
582,075
+8.9%
0.00%
-33.3%
Q1 2021$14,030,000
+31.9%
534,456
-6.1%
0.00%
+50.0%
Q4 2020$10,633,000
+5.5%
568,888
-4.2%
0.00%0.0%
Q3 2020$10,080,000
-30.0%
593,630
-4.0%
0.00%
-33.3%
Q2 2020$14,407,000
+211.2%
618,578
+12.3%
0.00%
+200.0%
Q1 2020$4,629,000
-15.1%
550,894
-1.3%
0.00%0.0%
Q4 2019$5,455,000
+3.0%
558,370
+0.1%
0.00%0.0%
Q3 2019$5,295,000
-21.8%
557,792
-2.2%
0.00%
-50.0%
Q2 2019$6,772,000
-35.7%
570,053
-4.6%
0.00%
-33.3%
Q1 2019$10,527,000
+8.1%
597,786
+6.5%
0.00%0.0%
Q4 2018$9,742,000
+13.1%
561,143
-2.9%
0.00%
+50.0%
Q3 2018$8,615,000
-3.2%
578,154
+3.2%
0.00%0.0%
Q2 2018$8,904,000
+14.0%
559,989
+1.8%
0.00%0.0%
Q1 2018$7,808,000
+2.1%
549,870
+0.7%
0.00%0.0%
Q4 2017$7,644,000
-3.3%
545,956
-1.3%
0.00%0.0%
Q3 2017$7,906,000
-10.0%
552,914
-0.8%
0.00%0.0%
Q2 2017$8,780,000
+16.0%
557,398
+1.6%
0.00%0.0%
Q1 2017$7,570,000
-18.6%
548,512
+4.4%
0.00%
-33.3%
Q4 2016$9,299,000
-6.5%
525,402
+1.9%
0.00%0.0%
Q3 2016$9,941,000
-0.1%
515,384
+1.0%
0.00%0.0%
Q2 2016$9,948,000
-4.1%
510,137
+1.3%
0.00%0.0%
Q1 2016$10,375,000
+1.4%
503,383
+1.0%
0.00%0.0%
Q4 2015$10,230,000
+25.0%
498,580
+4.2%
0.00%0.0%
Q3 2015$8,185,000
-8.7%
478,671
-0.5%
0.00%0.0%
Q2 2015$8,965,000
-2.5%
480,953
-0.2%
0.00%0.0%
Q1 2015$9,199,000
+5.7%
482,118
-8.8%
0.00%0.0%
Q4 2014$8,706,000
-18.6%
528,887
-12.5%
0.00%0.0%
Q3 2014$10,689,000
-15.8%
604,251
-1.8%
0.00%
-25.0%
Q2 2014$12,697,000
-17.8%
615,153
-13.3%
0.00%
-20.0%
Q1 2014$15,454,000
-23.5%
709,222
-6.8%
0.01%
-16.7%
Q4 2013$20,197,000
+11.8%
761,281
-0.4%
0.01%0.0%
Q3 2013$18,060,000
+8.6%
764,251
-1.2%
0.01%0.0%
Q2 2013$16,629,000773,4790.01%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q3 2022
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders